These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 3132198

  • 1. Plasma 5-S-cysteinyldopa as an index of melanogenesis.
    Nimmo JE, Gawkrodger DJ, O'Docherty CS, Going SM, Percy-Robb IW, Hunter JA.
    Br J Dermatol; 1988 Apr; 118(4):487-95. PubMed ID: 3132198
    [Abstract] [Full Text] [Related]

  • 2. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C, Rorsman H, Rosengren E, Tegner E.
    Acta Derm Venereol; 1981 Apr; 61(3):251-5. PubMed ID: 6167110
    [Abstract] [Full Text] [Related]

  • 3. Observations on PUVA treatment of psoriasis and on 5-S-cysteinyldopa after exposure to UV light.
    Tegner E.
    Acta Derm Venereol Suppl (Stockh); 1983 Apr; 107():1-68. PubMed ID: 6410637
    [No Abstract] [Full Text] [Related]

  • 4. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
    Kikuchi K, Wakamatsu K, Tada Y, Komine M, Ito S, Tamaki K.
    Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 5 years' experience of 5-S-cysteinyldopa in melanoma diagnosis.
    Agrup G, Agrup P, Andersson T, Hafström L, Hansson C, Jacobsson S, Jönsson PE, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1979 Nov; 59(5):381-8. PubMed ID: 93360
    [Abstract] [Full Text] [Related]

  • 7. Plasma 5-S-cysteinyldopa correlates with tumor size in melanoma-bearing mice.
    Hu F, Woodward WR, Peterson LL.
    J Invest Dermatol; 1988 Feb; 90(2):149-51. PubMed ID: 3123557
    [Abstract] [Full Text] [Related]

  • 8. 5-S-cysteinyldopa and pigment response to UVA light.
    Tegner E, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1983 Feb; 63(1):21-5. PubMed ID: 6191484
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
    Hansson C, Wirestrand LE, Aronsson A, Rorsman H, Rosengren E.
    Photodermatol; 1985 Apr; 2(2):52-7. PubMed ID: 3929237
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of melanin-related metabolites as markers of solar ultraviolet-B radiation.
    Wakamatsu K, Ito S.
    Pigment Cell Res; 2006 Oct; 19(5):460-4. PubMed ID: 16965276
    [Abstract] [Full Text] [Related]

  • 12. The effect of UVB light on serum concentrations of 5-S-cysteinyldopa.
    Tegner E, Agrup G, Rosengren E.
    Acta Derm Venereol; 1983 Oct; 63(2):149-52. PubMed ID: 6189331
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of melanogenesis in mouse and guinea pig hair by chemical analysis of melanins and of free and bound dopa and 5-S-cysteinyldopa.
    Ito S, Fujita K, Takahashi H, Jimbow K.
    J Invest Dermatol; 1984 Jul; 83(1):12-4. PubMed ID: 6429251
    [Abstract] [Full Text] [Related]

  • 14. Urinary excretion of 5-S-cysteinyldopa is enhanced by PUVA and is independent of skin type.
    Tardy J, Barrois JP, Bendelac A, Leonard F, Triller R, Jardillier JC, Kalis B.
    Photodermatol; 1987 Aug; 4(4):205-8. PubMed ID: 3124084
    [Abstract] [Full Text] [Related]

  • 15. Increased cysteinyldopa plasma levels hint to melanocyte as stress sensor in psoriasis.
    Panzella L, Wakamatsu K, Monfrecola G, Ito S, Ayala F, Napolitano A.
    Exp Dermatol; 2011 Mar; 20(3):288-90. PubMed ID: 21323749
    [Abstract] [Full Text] [Related]

  • 16. Plasma 5-S-cysteinyldopa concentrations in oculocutaneous albinism.
    Nimmo JE, Hunter JA, Percy-Robb IW, Jay B, Phillips CI, Taylor WO.
    Acta Derm Venereol; 1985 Mar; 65(2):169-71. PubMed ID: 2408424
    [Abstract] [Full Text] [Related]

  • 17. Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients.
    Wakamatsu K, Yokochi M, Naito A, Kageshita T, Ito S.
    Melanoma Res; 2003 Aug; 13(4):357-63. PubMed ID: 12883361
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion of 5-S-cysteinyldopa in relation to skin type, UVB-induced erythema, and melanocyte proliferation in human skin.
    Stierner U, Rosdahl I, Augustsson A, Kågedal B.
    J Invest Dermatol; 1988 Nov; 91(5):506-10. PubMed ID: 3139773
    [Abstract] [Full Text] [Related]

  • 19. The quantitative determination of 5-S-cysteinyldopa and dopa in normal serum and in serum from patients with malignant melanoma by means of high-pressure liquid chromatography.
    Hansson C, Edholm LE, Agrup G, Rorsman H, Rosengren AM, Rosengren E.
    Clin Chim Acta; 1978 Sep 15; 88(3):419-27. PubMed ID: 699334
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.